Form 4: Exelixis Executive Amy C. Peterson Reports Acquisition of 52,192 Shares of Common Stock

EVP Amy C. Peterson reports the acquisition of 52,192 shares of Exelixis common stock through the vesting of restricted stock units (RSUs).

Summary

• Amy C. Peterson, EVP of Product Development & Medical Affairs and CMO at Exelixis, Inc., reported a transaction on February 26, 2025.
• Peterson acquired 52,192 shares of Exelixis common stock through the vesting of restricted stock units (RSUs).
• The RSUs were granted under the Exelixis, Inc. 2017 Equity Incentive Plan.
• The RSUs vest in four equal installments, starting on May 15, 2026, and annually thereafter until fully vested.
• Following the reported transaction, Peterson beneficially owns 347,089 shares of Exelixis common stock, including 314,313 shares issuable upon vesting of RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction (RSU vesting) and an increase in executive ownership, which is generally viewed favorably.

Positives

• The acquisition of shares by an executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but it outlines the vesting schedule for the acquired RSUs, indicating a multi-year equity stake for the reporting person.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates that an executive is increasing their stake in the company, which is generally viewed positively by investors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company executive.

Key Dates